{"nct_id":"NCT00111475","title":"Evaluating the Safety and Efficacy of Romiplostim (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)","status":"COMPLETED","status_verified_date":"2019-12","start_date":"2002-07-01","start_date_type":"ACTUAL","primary_completion_date":"2004-06-17","primary_completion_date_type":"ACTUAL","completion_date":"2004-06-17","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["AMGN"]}